HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

question-icon

Does Persistent Use Of Perjeta, Taxotere And Carboplatin Cause Heart Damage?

default
Posted on Fri, 12 Feb 2016
Question: I recently was treated 6 rounds of perjeta, herceptin, taxotere and carboplatin for stage 2 Iib breast cancer. Had lumpectomy . Tumor did not shrink. Was due to start radiation but my oncologist wants me to do 4 rounds of FAC.. Had my last Herceptin on 12/2815. My concern is what will this do to my heart? Last muga was 63%.
doctor
Answered by Dr. Indranil Ghosh (1 hour later)
Brief Answer:
should not do much damage

Detailed Answer:
Hi
Thanks for your query.

Though some more details like full histopathology report would help, it appears that there was no or minimal pathological response to neoadjuvant chemo plus trastuzumab and pertuzumab. In that event further chemo with different combination like FAC is appropriate.

As cardiac function is normal now and FAC without concurrent trastuzumab is not much cardiotoxic, this should be fine. Other toxicities of FAC like oral ulcer, vomiting, diarrhea, neutrophil reduction, alopecia may be there.

I think you can go ahead with it.

Hope this helps.
Regards
Note: For further queries related to kidney problems Click here.

Above answer was peer-reviewed by : Dr. Chakravarthy Mazumdar
doctor
Answered by
Dr.
Dr. Indranil Ghosh

Oncologist

Practicing since :2004

Answered : 1712 Questions

premium_optimized

The User accepted the expert's answer

Share on

Get personalised answers from verified doctor in minutes across 80+ specialties

159 Doctors Online

By proceeding, I accept the Terms and Conditions

HCM Blog Instant Access to Doctors
HCM Blog Questions Answered
HCM Blog Satisfaction
Does Persistent Use Of Perjeta, Taxotere And Carboplatin Cause Heart Damage?

Brief Answer: should not do much damage Detailed Answer: Hi Thanks for your query. Though some more details like full histopathology report would help, it appears that there was no or minimal pathological response to neoadjuvant chemo plus trastuzumab and pertuzumab. In that event further chemo with different combination like FAC is appropriate. As cardiac function is normal now and FAC without concurrent trastuzumab is not much cardiotoxic, this should be fine. Other toxicities of FAC like oral ulcer, vomiting, diarrhea, neutrophil reduction, alopecia may be there. I think you can go ahead with it. Hope this helps. Regards